Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Matthew Snape from the Department of Paediatrics' Oxford Vaccine Group reveals promising findings from their current trial into a new Ebola vaccine.

Participate in our new ebola study

The persistence of vaccine-induced immunity to one year post-immunisation is truly impressive.

The fact that all participants retained Ebola-specific antibodies to the end of the study does raise hope that this vaccine could induce responses that last for several years.

- Dr Matthew Snape

'The world should be far better prepared for the next Ebola outbreak, with further promising results on Tuesday showing the potential of a long-lasting vaccine against the deadly virus.

'The two-part shot from Johnson & Johnson and Danish partner Bavarian Nordic induced a durable immune response lasting a full year in 100 percent of healthy volunteers vaccinated, researchers reported.' Extract from the Daily Mail, 14 March 2017.

The findings, based on a Phase I clinical trial led by the Oxford Vaccine Group involving 75 healthy subjects, were published in the Journal of the American Medical Association.

Read the full story in the Daily Mail.

Read the article published in Journal of the American Medical Association (JAMA).

 

See more media coverage:

Two-part Ebola vaccine offers long-lasting protection
Reuters online, 14/03/2017, Unattributed
http://www.reuters.com/article/us-health-ebola-vaccine-idUSKBN16L1X4

Two-part Ebola vaccine offers long-lasting protection
DNA India online, 14/03/2017, Unattributed
http://www.dnaindia.com/health/report-two-part-ebola-vaccine-offers-long-lasting-protection-2352657

Two-part Ebola vaccine offers long-lasting protection
Times of India online, 14/03/2017, Unattributed
http://timesofindia.indiatimes.com/business/international-business/two-part-ebola-vaccine-offers-long-lasting-protection/articleshow/57634704.cms


Two-part Ebola vaccine offers long-lasting protection
Channel NewsAsia online, 14/03/2017, Unattributed
http://www.channelnewsasia.com/news/health/two-part-ebola-vaccine-offers-long-lasting-protection/3595370.html

Experimental Ebola vaccine regimen induces durable immune response: study
Xinhua News Agency online, 14/03/2017, Unattributed
http://news.xinhuanet.com/english/2017-03/15/c_136128668.htm

Two-part Ebola vaccine offers long-lasting protection
Globe & Mail online, 15/03/2017, Unattributed
http://www.theglobeandmail.com/life/health-and-fitness/health/two-part-ebola-vaccine-offers-long-lasting-protection/article34307468/


Two-part Ebola vaccine offers long-lasting protection
Deccan Chronicle online, 15/03/2017, Unattributed
http://www.deccanchronicle.com/lifestyle/health-and-wellbeing/150317/two-part-ebola-vaccine-offers-long-lasting-protection.html

2-part Ebola vaccine found to be effective
CBC (Canada), 15/03/2017, via Reuters
http://www.cbc.ca/news/health/ebola-vaccine-j-j-1.4025807

‘Two-vaccine Ebola regimen may offer protection for a year’
DNA India, 15/03/2017, via PTI
http://www.dnaindia.com/health/report-two-vaccine-ebola-regimen-may-offer-protection-for-a-year-2353511